Eton Pharmaceuticals, Inc.ETONEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
Eton Pharmaceuticals, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative therapies for rare diseases, pediatric care and hospital care segments. It mainly operates in the U.S. market, partnering with medical stakeholders to deliver accessible high-quality treatments to underserved patients.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| Opaleye | 10.34% | 2.7M | ▲ +0.50pp | 2024-09-12 |
| EcoR1 Capital, LLC | 5.40% | 1.4M | — | 2024-12-09 |
| Harrow, | 0.00% | 2.0K | — | 2024-04-30 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-04-21 | RIEDEL NORBERT G | Director | Option exercise | 12.5K | $7.31 | $91.4K |
| 2026-04-21 | RIEDEL NORBERT G | Director | Option exercise | 19.7K | $8.61 | $169.2K |
1–2 of 2